Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
BEAM
Beam Therapeutics Inc.
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$24.45
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$2.53B
Country
USA
RECENT INSIDER TRADES
2026-10-02
· Cavanagh Bethany J
(SVP, Finance and Treasurer)
· SELL
2026-07-29
· Simon Amy
(Chief Medical Officer)
· SELL
2026-07-02
· Simon Amy
(Chief Medical Officer)
· SELL
2026-07-01
· Evans John M.
(CEO)
· OTHER
2026-07-01
· Evans John M.
(CEO)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
299
Shares held
130,527,268
Value
$4.17B
Percent of shares outstanding
126.37%
As of quarter end
2026-06-30
RECENT NEWS
Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress
BEAM: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
BEAM: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beam Therapeutics Inc. - BEAM
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS